IL116331A - Crystalline acid addition salts of 3-mercapto-1-(1,3-thiazolin-2-YL) azetidine and their production - Google Patents
Crystalline acid addition salts of 3-mercapto-1-(1,3-thiazolin-2-YL) azetidine and their productionInfo
- Publication number
- IL116331A IL116331A IL11633195A IL11633195A IL116331A IL 116331 A IL116331 A IL 116331A IL 11633195 A IL11633195 A IL 11633195A IL 11633195 A IL11633195 A IL 11633195A IL 116331 A IL116331 A IL 116331A
- Authority
- IL
- Israel
- Prior art keywords
- thiazolin
- mercapto
- acid addition
- addition salts
- azetidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Chemical Vapour Deposition (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Saccharide Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Processing Of Solid Wastes (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12749195A IL127491A (en) | 1994-12-12 | 1995-12-11 | Substituted 3-mercapto-1-(1,3-thiazolin-2-yl) azetidines and their preparation |
IL12749198A IL127491A0 (en) | 1994-12-12 | 1998-12-10 | Thiol compounds and their production |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33142394 | 1994-12-12 | ||
JP25728195 | 1995-09-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL116331A0 IL116331A0 (en) | 1996-03-31 |
IL116331A true IL116331A (en) | 2000-02-17 |
Family
ID=26543132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11633195A IL116331A (en) | 1994-12-12 | 1995-12-11 | Crystalline acid addition salts of 3-mercapto-1-(1,3-thiazolin-2-YL) azetidine and their production |
Country Status (15)
Country | Link |
---|---|
US (1) | US5659043A (de) |
EP (1) | EP0717042B1 (de) |
KR (1) | KR100337053B1 (de) |
AT (1) | ATE201410T1 (de) |
AU (1) | AU703119B2 (de) |
CA (1) | CA2164918C (de) |
DE (1) | DE69521012T2 (de) |
DK (1) | DK0717042T3 (de) |
ES (1) | ES2156917T3 (de) |
FI (1) | FI120402B (de) |
GR (1) | GR3035925T3 (de) |
HU (4) | HU223472B1 (de) |
IL (1) | IL116331A (de) |
NO (1) | NO955007L (de) |
PT (1) | PT717042E (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100451670B1 (ko) * | 2001-09-14 | 2004-10-08 | 한국화학연구원 | 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법 |
KR100621782B1 (ko) * | 2004-06-14 | 2006-09-19 | 한국과학기술연구원 | 1-베타메틸카바페넴 유도체 및 이의 제조방법 |
CN102532139A (zh) * | 2010-12-07 | 2012-07-04 | 重庆医药工业研究院有限责任公司 | 一种替比培南的制备方法 |
CN102731502B (zh) * | 2011-04-13 | 2016-08-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种碳青霉烯抗生素的制备方法 |
CN102731503B (zh) * | 2011-04-13 | 2016-02-03 | 石药集团中奇制药技术(石家庄)有限公司 | 一种泰比培南的制备方法 |
CN102250080B (zh) * | 2011-04-26 | 2015-06-03 | 广州白云山制药股份有限公司广州白云山制药总厂 | 一种1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁叮盐酸盐的制备方法 |
CN102757430B (zh) * | 2011-04-29 | 2016-04-13 | 上海医药工业研究院 | 一种替比培南的制备方法 |
CN104292222B (zh) * | 2013-07-17 | 2017-05-10 | 常州锐博生物科技有限公司 | 一种替比培南匹伏酯侧链的新的合成方法 |
RU2022103033A (ru) | 2015-07-02 | 2022-04-01 | ХОРАЙЗОН ОРФАН ЭлЭлСи | Цистеаминдиоксигеназа-резистентные аналоги цистеамина и их применение |
CN112321582B (zh) * | 2020-11-03 | 2021-12-03 | 江西富祥药业股份有限公司 | 一种泰比培南侧链的合成及中间体的精制方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU682510B2 (en) * | 1993-07-01 | 1997-10-09 | Pfizer Japan Inc. | 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives |
-
1995
- 1995-12-11 AT AT95119485T patent/ATE201410T1/de active
- 1995-12-11 NO NO955007A patent/NO955007L/no unknown
- 1995-12-11 CA CA002164918A patent/CA2164918C/en not_active Expired - Lifetime
- 1995-12-11 DE DE69521012T patent/DE69521012T2/de not_active Expired - Lifetime
- 1995-12-11 DK DK95119485T patent/DK0717042T3/da active
- 1995-12-11 PT PT95119485T patent/PT717042E/pt unknown
- 1995-12-11 EP EP95119485A patent/EP0717042B1/de not_active Expired - Lifetime
- 1995-12-11 IL IL11633195A patent/IL116331A/xx not_active IP Right Cessation
- 1995-12-11 ES ES95119485T patent/ES2156917T3/es not_active Expired - Lifetime
- 1995-12-12 FI FI955954A patent/FI120402B/fi not_active IP Right Cessation
- 1995-12-12 AU AU40359/95A patent/AU703119B2/en not_active Expired
- 1995-12-12 HU HU0203890A patent/HU223472B1/hu active IP Right Grant
- 1995-12-12 HU HU0203892A patent/HU223477B1/hu active IP Right Grant
- 1995-12-12 US US08/570,888 patent/US5659043A/en not_active Expired - Lifetime
- 1995-12-12 KR KR1019950048784A patent/KR100337053B1/ko not_active IP Right Cessation
- 1995-12-12 HU HU0203891A patent/HU223476B1/hu active IP Right Grant
- 1995-12-12 HU HU9503548A patent/HU223536B1/hu active IP Right Grant
-
2001
- 2001-05-24 GR GR20010400749T patent/GR3035925T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO955007D0 (no) | 1995-12-11 |
PT717042E (pt) | 2001-08-30 |
HU0203891D0 (en) | 2003-01-28 |
DE69521012T2 (de) | 2001-09-06 |
DE69521012D1 (de) | 2001-06-28 |
AU4035995A (en) | 1996-06-20 |
HU223536B1 (hu) | 2004-08-30 |
HU223477B1 (hu) | 2004-07-28 |
DK0717042T3 (da) | 2001-08-06 |
HUT75098A (en) | 1997-04-28 |
FI955954A (fi) | 1996-06-13 |
HU9503548D0 (en) | 1996-02-28 |
CA2164918C (en) | 2007-09-25 |
GR3035925T3 (en) | 2001-08-31 |
HU0203890D0 (en) | 2003-01-28 |
CA2164918A1 (en) | 1996-06-13 |
HU0203892D0 (en) | 2003-01-28 |
ATE201410T1 (de) | 2001-06-15 |
US5659043A (en) | 1997-08-19 |
KR960022512A (ko) | 1996-07-18 |
IL116331A0 (en) | 1996-03-31 |
EP0717042B1 (de) | 2001-05-23 |
FI120402B (fi) | 2009-10-15 |
ES2156917T3 (es) | 2001-08-01 |
HU223472B1 (hu) | 2004-07-28 |
AU703119B2 (en) | 1999-03-18 |
KR100337053B1 (ko) | 2002-11-07 |
NO955007L (no) | 1996-06-13 |
HU223476B1 (hu) | 2004-07-28 |
FI955954A0 (fi) | 1995-12-12 |
EP0717042A1 (de) | 1996-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO306780B1 (no) | Carbapenem-antibiotika | |
IL116331A (en) | Crystalline acid addition salts of 3-mercapto-1-(1,3-thiazolin-2-YL) azetidine and their production | |
GR3024653T3 (en) | Process for producing alpha-ketoamide derivative | |
DE69901627T2 (de) | Verfahren zur Herstellug von 3-Amino-pyrrolidinderivaten | |
AU5778996A (en) | Processes for preparing cyclic compounds | |
DE69109913D1 (de) | Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte. | |
PH30984A (en) | Process for the preparation of aminotriazine derivatives. | |
BR8502884A (pt) | Derivado de azetidina e processo para preparar acido azetidino-3-carboxilico | |
GR3015422T3 (en) | Thiadiazolylacetamide cephem derivatives. | |
HUT63829A (en) | Process for producing (s)-vinyl- and allenyl-gabe, as well as (s)-vinyl- and allenyl-pyrrolidinone | |
GR3030649T3 (en) | Glyceraldehyde-3-pentanide and process for producing same | |
NO883297D0 (no) | Substituerte carbapenem-3-karboksylsyrederivater. | |
HU0204401D0 (en) | Process for producing 2,6-dichlorophenol derivatives | |
ATE244228T1 (de) | Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
HC | Change of name of proprietor(s) | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |